Approving a Problematic Muscular Dystrophy Drug: Implications for FDA Policy. - PubMed - NCBI

Approving a Problematic Muscular Dystrophy Drug: Implications for FDA Policy. - PubMed - NCBI

JAMA. 2016 Oct 24. doi: 10.1001/jama.2016.16437. [Epub ahead of print]

Approving a Problematic Muscular Dystrophy Drug: Implications for FDA Policy.

Kesselheim AS1, Avorn J1.

Author information

PMID:

 

27775756

 

DOI:

 

10.1001/jama.2016.16437

[PubMed - as supplied by publisher]